Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2022-06-03 00:00:00 ET · period of report 2022-06-01 · accession 0001209191-22-033965 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-03 | 2022-06-01 | IRWD | Dreyfus Andrew | Dir | A - Grant | $0.00 | +21.6K | 151.6K | +17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-06-01 | A | A | 21,571 | $0.00 | 151,639 | D | — | — | (F2) The total amount of shares beneficially owned has been adjusted to correct prior immaterial computational errors. |